A prospective comparative study of Knowlesi, falciparum, and vivax malaria in sabah, Malaysia: High proportion with severe disease from plasmodium knowlesi and plasmodium vivax but No mortality with early Referral and artesunate therapy

Clinical Infectious Diseases

Volumn 56, Issue 3, 2013, Pages 383-397

  Barber, Bridget E ^a,d   William, Timothy ^a,b,c   Grigg, Matthew J ^a,d   Menon, Jayaram ^b,c   Auburn, Sarah ^d   Marfurt, Jutta ^d   Anstey, Nicholas M ^d,e   Yeo, Tsin W ^d,e  

^a Infectious Diseases Unit   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c Sabah Department of Health   (Malaysia)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

malaria; Plasmodium knowlesi; Plasmodium vivax

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; CHLOROQUINE; PRIMAQUINE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; HUMAN; HYPOTENSION; JAUNDICE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALAYSIA; MALE; OUTCOME ASSESSMENT; PARASITEMIA; PLASMODIUM KNOWLESI MALARIA; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTIMALARIALS; ARTEMISININS; FEMALE; HUMANS; MALARIA; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALAYSIA; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM VIVAX; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872341743     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis902     Document Type: Article

References (37)

1. Barber BE, William T, Jikal M, et al. Plasmodium knowlesi malaria in children. Emerg Infect Dis 2011; 17:814-20.
2. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008; 46:165-71.
3. Daneshvar C, Davis TM, Cox-Singh J, et al. Clinical and laboratory features of human Plasmodium knowlesi infection. Clin Infect Dis 2009; 49:852-60.
4. Joveen-Neoh WF, Chong KL, Wong CM, Lau TY. Incidence of malaria in the Interior Division of Sabah, Malaysian Borneo, based on nested PCR. J Parasitol Res 2011 [Epub ahead of print] .
5. Cox-Singh J. Zoonotic malaria: Plasmodium knowlesi, an emerging pathogen. Curr Opin Infect Dis 2012; 25:530-6.
6. Cox-Singh J, Hiu J, Lucas SB, et al. Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings. Malar J 2010; 9:10.
7. William T, Menon J, Rajahram G, et al. Severe Plasmodium knowlesi malaria in a tertiary hospital, Sabah, Malaysia. Emerg Infect Dis 2011; 17:1248-55.
8. Rajahram G, Barber BE, William T, Menon J, Anstey NM, Yeo TW. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as P. malariae and delayed parenteral artesunate. Malar J 2012; 11:284.
9. World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva, Switzerland: WHO; 2010.
10. Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996; 335:76-83.
11. Imwong M, Tanomsing N, Pukrittayakamee S, Day NPJ, White NJ, Snounou G. Spurious amplification of a Plasmodium vivax smallsubunit RNA gene by use of primers currently used to detect P. knowlesi. J Clin Microbiol 2009; 47:4173.
12. Padley D, Moody A, Chiodini P, Saldanha J. Use of a rapid, singleround, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol 2003; 97:131-7.
13. Lee CE, Adeeba K, Freigang G. Human Plasmodium knowlesi infections in Klang Valley, peninsular Malaysia: a case series. Med J Malaysia 2010; 65:63-5.
14. Daneshvar C, Davis TM, Cox-Singh J, et al. Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections. Malar J 2010; 9:238.
15. Dondorp AM, Lee SJ, Faiz M, et al. The relationship between age and the manifestations of and mortality associated with severe malaria. Clin Infect Dis 2008; 47:151.
16. Yeo TW, Lampah DA, Tjitra E, et al. Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospectivestudy in Papua, Indonesia. J Infect Dis 2010; 202:109-12.
17. Ross R, Thomson D. Some enumerative studies on malarial fever.Proc R Soc Lond B Biol Sci 1910; 83:159-73.
18. Dondorp A, Pongponratn E, White N. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electronmicroscopic pathology. Acta Trop 2004; 89:309-17.
19. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204:2693-704.
20. Pongponratn E, Turner GDH, Day NPJ, et al. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 2003; 69:345-59.
21. Turner GDH, Morrison H, Jones M, et al. An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule- 1 in cerebral sequestration. Am J Pathol 1994; 145:1057.
22. Fatih FA, Siner A, Ahmed A, et al. Cytoadherence and virulence - the case of Plasmodium knowlesi malaria. Malar J 2012; 11:33.
23. Knisely MH, Stratman-Thomas WK. Knowlesi malaria in monkeys; microscopic pathological circulatory physiology of rhesus monkeys during acute Plasmodium knowlesi malaria. J Natl Mal Soc 1945; 4:285.
24. Knisely MH, Stratman-Thomas WK. Microscopic observations of intravascular agglutination of red cells and consequent sludging of blood in rhesus monkeys infected with knowlesi malaria. Anat Rec 1948; 101:701.
25. Demar M, Legrand E, Hommel D, Esterre P, Carme B. Plasmodium falciparum malaria in splenectomized patients: two case reports in French Guiana and a literature review. Am J Trop Med Hyg 2004; 71:290-3.
26. Pauzner R, Goldschmied-Reouven A, Hay I, et al. Delayed parasite clearance in a splenectomized patient with falciparum malaria who was treated with artemisinin derivatives. Clin Infect Dis 1997:923-5.
27. Looareesuwan S, Suntharasamai P, Webster HK, Ho M. Malaria in splenectomized patients: report of four cases and review. Clin InfectDis 1993; 16:361.
28. Bachmann A, Esser C, Petter M, et al. Absence of erythrocyte sequestration and lack of multicopy gene family expression in Plasmodium falciparum from a splenectomized malaria patient. PLoS One 2009; 4:e7459.
29. Nguansangiam S, Day NPJ, Hien TT, et al. A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria. Trop Med Int Health 2007; 12:1037-50.
30. Anstey NM, Douglas NM, Poespoprodjo JR, Price R. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012. In press.
31. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 2009; 22:430.
32. Tjitra E, Anstey NM, Sugiarto P, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective studyin Papua, Indonesia. PLoS Med 2008; 5:e128.
33. Genton B, D'Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008; 5:e127.
34. Kochar DK, Das A, Kochar SK, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg 2009; 80:194-8.
35. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007; 77:984-91.
36. Lacerda MVG, Fragoso SCP, Alecrim MGC, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 2012.
37. World Health Organization. World Malaria Report 2011. Geneva, Switzerland: WHO; 2011. Available at: http://www.who.int/malaria/ world-malaria-report-2011/9789241564403-eng.pdf. Accessed 10 July 2012.